Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05034718 · ClinicalTrials.gov registry record · NA

Implementation of the Pittsburgh Infant Brain Injury Score

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
1,989
Enrollment target

NCT05034718: Completed NA study, sponsored by University of Pittsburgh.

NCT05034718 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,989 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05034718, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
1,989 participants
Enrollment target

Study Summary

This is an implementation study of the Pittsburgh Infant Brain Injury Score (PIBIS) into the UPMC Children's Hospital of Pittsburgh emergency department. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.

Primary Outcome

Children identified as eligible by Cerner and confirmed by the nurse powerform as eligible for PIBIS will also be determined to be eligible after chart review and discussion with the clinician (which is how eligibility was determined during the validation study). The primary outcome will be the concordance between these two methods of determining eligibility. A concordance of \>90% is the goal.

Interventions

  • OTHER Standard of care
  • OTHER PIBIS clinical decision support

Trial Details

FieldValue
Enrollment Target 1,989 participants
Start Date 2021-07-05
Est. Completion 2023-12-31
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT05034718 record still lists

NCT05034718 is an interventional study that assigns participants to a tested intervention. Its 1,989 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).

The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.

NCT05034718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05034718 about?

NCT05034718 is a clinical study titled "Implementation of the Pittsburgh Infant Brain Injury Score". This is an implementation study of the Pittsburgh Infant Brain Injury Score (PIBIS) into the UPMC Children's Hospital of Pittsburgh emergency department. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validati...

What is the current status of trial NCT05034718?

This trial is currently completed. It is a NA study. The enrollment target is 1,989 participants. The study started on 2021-07-05. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT05034718?

The interventions under investigation include: Standard of care (OTHER), PIBIS clinical decision support (OTHER).

Who is sponsoring clinical trial NCT05034718?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05034718's enrollment target sits among peer trials

1,989 54th of 2000 higher than 1,947 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06062394 · 1,980 participants · NA

    Penn Medicine Healthy Heart

  • NCT07321886 · 1,980 participants · Phase 3

    A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05034718, the US trial registry maintained by the National Library of Medicine. NCT05034718 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.